Michelle Kirschner, Managing Director of the International Cancer Rehabilitation Foundation, Clinical Lead and Medical Advisory Board Chairman at OneVillage, shared on LinkedIn:
“Over the past year, I’ve been challenged to rethink what advocacy really means.
Like many people in healthcare, I often associated advocacy with policy change. While policy remains incredibly important, I’ve come to realize that some of the most impactful advocacy happens in other ways:
- A survivor builds a solution they wish existed.
- A clinician develops a program that expands access.
- A nonprofit creates educational resources that help people navigate life after cancer.
- An advocate raises awareness about services people didn’t know were available.
These efforts may not make headlines, but they change lives every day.
My newest article, ‘Oncology Advocacy 2.0: Building a More Diverse Portfolio for Change,’ explores why we need a broader definition of advocacy and how each of us can contribute using our unique skills and experiences.
I hope it encourages others to see new opportunities to create impact.
Please share and spread the word.
Other articles featuring Michelle Kirschner on OncoDaily.